On November 13, 2022, in the Atomium in Brussels, Leo Pharma launched its new drug: Adtralza, a monoclonal antibody that blocks the action of a protein called IL-13. It is suitable for treating adults with moderate to severe atopic eczema. On behalf of Tamara Twist, Cmore is providing an aftermovie featuring interviews with the key opinion leaders, and the attending physicians.

Cmore also takes care of the live connections with 2 european speakers who are not physically present, and who are brought to the screen in the Atomium. Two way communication in both image and sound.